InflaRx IFRX
NASDAQ IFRX
$1.23 -0.08 (-6.49%)
As of: Nov 10, 2026 · 2:59 PM EST

InflaRx (IFRX) Current Leases (2019 - 2022)

Updated

InflaRx (IFRX) recorded Current Leases of $368,149 in Q3 2022, down 12.8% from $422,154 a year earlier.

Analysis

InflaRx (IFRX) Current Leases (2019 - 2022) Analysis & Trends

At the end of FY2021, InflaRx reported Current Leases of $414,690, down 0.4% from FY2020.

  • Across earlier years, Current Leases came in at $416,371 in FY2020 (-27.7%) and $575,612 in FY2019.
  • The Q3 2022 figure is the lowest quarterly Current Leases in data going back to Q4 2019.
  • On a year-over-year basis, Current Leases rose in 1 of the last six quarters, with an average decline of 15.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 InflaRx 85.79 Mn -160.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 368,149.30
Mar 31, 2022 412,626.26
Dec 31, 2021 414,689.68
Sep 30, 2021 422,154.45
Mar 31, 2021 388,014.96
Dec 31, 2020 416,371.18
Sep 30, 2020 600,784.37
Jun 30, 2020 589,391.63
Mar 31, 2020 564,869.09
Dec 31, 2019 575,612.12
API Access

InflaRx Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=IFRX&period=max&api_key=YOUR_API_KEY